Alfresa
Produits pharmaceutiques et médicaux pour les prestataires de soins de santé
Alfresa distribue des médicaments sur ordonnance, des produits médicaux et des fournitures de diagnostic. Son réseau dessert les pharmacies et les établissements de santé à travers le Japon.
- Type
- distributor (our classification of the record, not a statement by the company)
- Role
- Distributor
- Location
- Tokyo, Japan
- Website
- alfresa.com
- Categories
- Production pharmaceutique, Fournitures médicales et de santé
- Markets
- Japon
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-04 Mail server of the company domain
- domain-registered (green), checked 2026-08-04 Domain registry record
- sanctions-clear (green), checked 2026-08-04 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- debarment-clear (green), checked 2026-08-04 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- fda-registered (green), checked 2026-08-04 FDA
- web-presence-since (green), checked 2026-08-03 Internet Archive (Wayback)
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)